Novo Nordisk (NVO) has released an update.
Novo Nordisk A/S, a leading global healthcare company, has launched a share repurchase program buying back B shares for up to DKK 2.4 billion, as part of a larger DKK 20 billion program set to run over 12 months starting from February 2024. They have already repurchased 12,023,313 B shares at an average price of DKK 880.98 per share, totaling a value of DKK 10,592,256,521. The company continues to bolster its capital structure and provide value to its shareholders through these strategic buybacks.
For further insights into NVO stock, check out TipRanks’ Stock Analysis page.
